IQVIA – New AI Products and Veeva Partnership Enhance My Buy Thesis

IQVIA Holdings (IQV, i) remains an absolute favorite of mine in the pharmaceutical services sector. At the TechIQ conference on October 7, the company presented the new Life Science Models. This allows clinical trials to be simulated before they start and risks to be identified earlier. In an initial evaluation of 50 studies with 270 endpoints, 85% of the forecasts were within the target range or clinically close to it. The models based on technologies from NVIDIA and AWS could avoid costly misplanning. This complements Predictive Clinical Development,...